This Company Is Essential To Biotechs – And Its Shares May Be Poised To Break Out
“The company I’m showing you today is essential to biotech stocks. It’s a ‘biotech-enabler,’” declares the author of today’s article in regards to a firm…
stock market
The FDA To Give This Biotech’s Potential Blockbuster Alzheimer’s Drug A Rapid Review
If the biotech highlighted in today’s article ends up getting its drug approved, it would be the first Alzheimer’s treatment that actually reduces the cognitive…
COVID & Psychedelics: 3 Biotech Penny Stocks To Watch In August
“With coronavirus cases climbing in the U.S., this is likely going to be a clear focus for quite some time,” declares the author of today’s…
“The Era Of Biotechs”
“The paralyzing viral outbreak that has swept the planet, costing trillions in output and gumming up the wheels of the global economy has also created…
4 “Hidden Tech Gems” In The Much Appreciated Sector
“Investors have rewarded tech stocks richly during, and prior to the pandemic. Yet, there are gems that remain hidden within the sector,” advises the author…
Profit From The Coming Battery Boom With This Lithium Leader
If your phone or car uses a lithium-ion battery, the company highlighted in today’s article likely manufactured the lithium chemical used in that battery –…
3 “Strong Buy” Penny Stocks With Massive Upside Potential For Risk-Tolerant Investors
The market strategist cited in today’s article believes that the current stock market situation will get “resolved to the upside” – and for risk-tolerant investors…
What To Know About These Top Biotech Stocks To Watch
“July is a critical month for several leading biotech companies, and there’s a lot that investors need to know if they want to make a…
Options For An Uncertain Earnings Season
With second-quarter earnings season getting underway against what the author of today’s article acknowledges is “one of the most uncertain backdrops ever”, he advises that…
These 5 “Magic Formula” Biotech Stocks Are Guru Approved
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…